CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Sevilla, Spain and 205 other locations
with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...
Phase 3
Sevilla, Spain and 139 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Sevilla, Andalucia, Spain and 122 other locations
The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tole...
Phase 2
Sevilla, Spain and 23 other locations
over time. The third main question is to see if ELVN-002 works to shrink cancers that have HER2 genetic abnormalities, particularly non-sma ...
Phase 1
Sevilla, Spain and 36 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
Sevilla, Spain and 123 other locations
docetaxel in patients with advanced or metastasized non-small cell lung cancer (NSCLC) and unresectable NSCLC after chemoradiothera...
Phase 1
Sevilla, Spain and 33 other locations
study was designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung...
Phase 3
Sevilla, Spain and 198 other locations
, early-stage non-small cell lung cancer....
Phase 2
Sevilla, Spain and 94 other locations
sub- studies. Sub-study 1 includes participants with non-small cell lung cancer (NSCLC) with high programmed cell death protein lig...
Phase 2
Sevilla, Spain and 62 other locations
Clinical trials
Research sites
Resources
Legal